Patent Applications published on Jul 4, 2024 - page 4

#901
US20240216372A1
Human necessities

THERAPEUTICS FOR KELOIDS AND OTHER FIBROTIC DISORDERS

#902
US20240216373A1
Human necessities

LIQUID DOSAGE FORMS OF IMATINIB

#903
US20240216374A1
Human necessities

COMPOSITE VITAMIN COMPOSITION PROMOTING GASTROINTESTINAL SYSTEM MOTILITY

#904
US20240216375A1
Human necessities

USE OF SYMPATHETIC ACTIVATION INHIBITOR AND/OR ALPHA 1-ADRENERGIC RECEPTOR INHIBITOR IN PREPARING MEDICINE FOR TREATING DRY EYES

#905
US20240216376A1
Human necessities

COMBINATION THERAPIES FOR THE TREATMENT OF CANCER

#906 ✅ Patent 12,201,636 granted on 2025-01-21
US20240216377A1
Human necessities

Heterocyclylamines as PI3K inhibitors

#907
US20240216378A1
Human necessities

TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF

#908
US20240216379A1
Human necessities

7-BENZYL-4-(METHYLBENZYL)-2,4,6,7,8,9-HEXAHYDROIMIDAZ0[1,2-A]PYRID0[3,4-E] PYRIMIDIN-5 (1 H)-ONE, SALTS THEREOF AND METHODS OF USING THE SAME IN COMBINATION THERAPY

#909
US20240216380A1
Human necessities

BTK Inhibitors to Treat Solid Tumors Through Modulation of the Tumor Microenvironment

#910
US20240216381A1
Human necessities

Px-cholorogenic Acid Comps

#911
US20240216382A1
Human necessities

PEDIATRIC POWDER FOR ORAL SUSPENSION CONTAINING ANTIVIRAL AGENT AND METHOD FOR THE PREPARATION THEREOF

#912
US20240216383A1
Human necessities

FORMULATIONS AND METHODS FOR TREATING ERECTILE DYSFUNCTION

#913
US20240216384A1
Human necessities

COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASES, CONTAINING TRICYCLO DERIVATIVE COMPOUND

#914
US20240216385A1
Human necessities

A PI3K-DELTA INHIBITOR FOR THE TREATMENT OF PANCREATIC CANCER

#915
US20240216386A1
Human necessities

MODULATORS OF RHO-ASSOCIATED PROTEIN KINASE

#916
US20240216387A1
Human necessities

COMPOSITION FOR PREVENTING OR TREATING MUSCULAR DISEASE, COMPRISING OXICAM-BASED COMPOUND

#917
US20240216388A1
Human necessities

INHIBITOR OF SUV39H1 HISTONE METHYLTRANSFERASE FOR USE IN CANCER COMBINATION THERAPY

#918
US20240216389A1
Human necessities

DRUG FOR PREVENTING AND/OR TREATING POLYCYSTIC KIDNEY DISEASE

#919
US20240216390A1
Human necessities

THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE

#920
US20240216391A1
Human necessities

TREATING FIBROSIS WITH A CCK RECEPTOR INHIBITOR

#921
US20240216392A1
Human necessities

METHODS OF TREAMENT

#922
US20240216393A1
Human necessities

ALTRENOGEST INJECTION AND PREPARATION METHOD AND USE THEREOF

#923
US20240216394A1
Human necessities

GOLEXANOLONE FOR USE IN THE TREATMENT OF FATIGUE OR COGNITIVE IMPAIRMENT IN LIVER DISEASE PATIENTS

#924
US20240216395A1
Human necessities

19-NOR C3,3-DISUBSTITUTED C21 -N-PYRAZOLYL STEROID FOR USE IN TREATING MAJOR DEPRESSIVE DISORDER AND POSTPARTUM DEPRESSION

#925
US20240216396A1
Human necessities

NEUROACTIVE STEROID FOR USE IN TREATING MAJOR DEPRESSIVE DISORDER AND POSTPARTUM DEPRESSION IN A LACTATING FEMALE

#926
US20240216397A1
Human necessities

COMPOSITION FOR AMELIORATING SKIN TISSUE ABNORMALITY

#927
US20240216398A1
Human necessities

CANNABINOID-CONTAINING COMPLEX MIXTURES FOR THE TREATMENT OF CYTOKINE RELEASE SYNDROME WHILE PRESERVING KEY ANTI-VIRAL IMMUNE REACTIONS

#928
US20240216399A1
Human necessities

CANNABINOID COMPOSITION AND METHOD OF USING THE SAME

#929
US20240216401A1
Human necessities

COMBINATION THERAPY BY USING AKR1C3-ACTIVATED COMPOUND WITH IMMUNE CHECKPOINT INHIBITOR

#930
US20240216402A1
Human necessities

PHARMACEUTICAL COMPOSITION, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#931
US20240216403A1
Human necessities

METHODS AND COMPOSITIONS FOR INHIBITING FIBROBLAST ACTIVATION

#932
US20240216404A1
Human necessities

METHODS OF TREATING HEART FAILURE WITH REDUCED EJECTION FRACTION

#933
US20240216405A1
Human necessities

MOUSE MODEL AND TREATMENT OF HEREDITARY INCLUSION BODY MYOPATHY

#934
US20240216406A1
Human necessities

METHODS AND COMPOSITIONS FOR SUPPORTING HUMAN HEALTH DURING SPACE TRAVEL

#935
US20240216407A1
Human necessities

NOVEL POLYPHENOL COMPOUND

#936
US20240216408A1
Human necessities

ANTIOXIDANT COMPOSITION COMPRISING POLYDATIN AND ACETYLCYSTEINE

#937
US20240216409A1
Human necessities

Patient Treatment Via Teratogenic Pharmaceutical Compounds

#938
US20240216410A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING CANCER THERAPY-INDUCED NEUTROPENIC FEVER AND/OR GVHD

#939
US20240216411A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS CLASS I MUTATIONS

#940
US20240216412A1
Human necessities

OXIDIZED NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) PRECURSOR TREATMENT FOR HEART FAILURE ALLEVIATION INDEPENDENT OF MITOCHONDRIAL PROTEIN DEACETYLATION

#941
US20240216413A1
Human necessities

THIONUCLEOSIDES AS ANTIVIRAL AGENTS

#942
US20240216414A1
Human necessities

Antiviral Agents and Nucleoside Analogs for Treatment of Zika Virus

#943
US20240216415A1
Human necessities

DEOXY-CYTIDINE OR URIDINE DERIVATIVES FOR USE IN CANCER THERAPIES

#944
US20240216416A1
Human necessities

METHOD OF TREATING BREAST CANCER IN A SUBJECT BY INHIBITING TUBB2B

#945 ✅ Patent 12,268,705 granted on 2025-04-08
US20240216417A1
Human necessities

Use of polysaccharide for treating ST-elevation myocardial infarction and diseases of the digestion system

#946
US20240216418A1
Human necessities

Prevention and Treatment of Periodontal and Peri-Implant Disease

#947
US20240216419A1
Human necessities

SULFATED OLIGOSACCHARIDES HAVING ANTI-INFLAMMATORY ACTIVITY

#948
US20240216420A1
Human necessities

HYDROPHOBIC AURISTATIN F COMPOUNDS AND CONJUGATES THEREOF

#949
US20240216421A1
Human necessities

COMBINATION PRODUCT AND METHODS FOR PREVENTING THE EMERGENCE OF ANTIBIOTIC-RESISTANT BACTERIA UNDER ANTIBIOTIC TREATMENT

#950
US20240216422A1
Human necessities

REMEDIATION OF ALL DISEASES CAUSED BY RADIATION RELATED REACTIVE ION SPECIES ARE ALL CORRECTABLE BY H2S - SO2 GENERATED BY FDA-STS SODIUM THIOSULFATE, NA2S203

#951
US20240216423A1
Human necessities

INHIBITION OF CRYSTALLIZATION AND/OR BIOFILM FORMATION ON AN INDWELLING URINARY CATHETER

#952
US20240216424A1
Human necessities

CISPLATIN PARTICLES AND USES THEREOF

#953
US20240216425A1
Human necessities

Engineered Macrophages for Cancer Immunotherapy

#954
US20240216426A1
Human necessities

RECOMBINANT ANTIGEN PRESENTING CELLS

#955
US20240216427A1
Human necessities

CHIMERIC ANTIGEN RECEPTORS TARGETING SPLICE VARIANTS OF THE EXTRACELLULAR MATRIX PROTEINS TENASCIN C (TNC) AND PROCOLLAGEN 11A1 (COL11A1)

#956
US20240216428A1
Human necessities

Novel Anti-CD5 Chimeric Antigen Receptor and Immune Cell Expressing Same

#957
US20240216429A1
Human necessities

CHIMERIC ANTIGEN RECEPTOR SYSTEM WITH ADAPTABLE RECEPTOR SPECIFICITY

#958
US20240216430A1
Human necessities

CLAUDIN 18.2 TARGETING CHIMERIC ANTIGEN RECEPTORS AND BINDING AGENTS AND USES THEREOF

#959
US20240216431A1
Human necessities

METHODS FOR EXPANSION OR DEPLETION OF T-REGULATORY CELLS

#960
US20240216432A1
Human necessities

ANTI-FLT3 ANTIBODIES, CARS, CAR T CELLS AND METHODS OF USE

#961
US20240216433A1
Human necessities

METHODS AND SYSTEMS FOR PREPARATION OF MONONUCLEAR-PLATELET RICH FIBRIN MATRIX, AND COMPOUNDS THEREOF

#962
US20240216434A1
Human necessities

NUTRITIONAL COMPOSITIONS FOR HUMAN CONSUMPTION AND METHODS FOR MAKING SAME

#963
US20240216435A1
Human necessities

COMPOSITION FOR SKIN REGENERATION, WHITENING, ANTIOXIDATION, OR WOUND TREATMENT, COMPRISING STEM CELL-DERIVED EXOSOME AS ACTIVE INGREDIENT, AND USE THEREOF

#964
US20240216436A1
Human necessities

INTERFERON GAMMA-PRIMED MESENCHYMAL STROMAL CELLS AS PROPHYLAXIS FOR GRAFT VERSUS HOST DISEASE

#965
US20240216437A1
Human necessities

METHODS AND COMPOSITIONS FOR TREATING OCULAR GRAFT VERSUS HOST DISEASE AND OTHER OCULAR CONDITIONS

#966
US20240216438A1
Human necessities

COMPOSITION CONTAINING FUNCTION-REINFORCED STEM CELL FOR PREVENTION OR TREATMENT OF ATOPIC DERMATITIS

#967
US20240216439A1
Human necessities

COMPOSITIONS OF CELLS WITH AN ENHANCED THERAPEUTIC CAPACITY

#968
US20240216440A1
Human necessities

STRING-LIKE AGGREGATES OF RETINAL PIGMENT EPITHELIAL CELLS, DEVICE AND PRODUCTION METHOD FOR PRODUCING SAME, AND THERAPEUTIC AGENT COMPRISING SAID STRING-LIKE AGGREGATES

#969
US20240216441A1
Human necessities

AGENT FOR IMPROVING CANCER CACHEXIA AND METHOD FOR IMPROVING CANCER CACHEXIA

#970 ✅ Patent 12,144,831 granted on 2024-11-19
US20240216442A1
Human necessities

Sterile human placental allografts having a plurality of slits, openings, and/or fenestrations formed thereon

#971
US20240216443A1
Human necessities

A MYCOBACTERIUM FOR USE IN CANCER THERAPY

#972
US20240216444A1
Human necessities

DESIGNED BACTERIAL COMPOSITIONS

#973
US20240216445A1
Human necessities

WEISSELLA CIBARIA GSKM06 AND USE THEREOF

#974
US20240216446A1
Human necessities

PROBIOTIC COMPOSITIONS USEFUL IN THE PREVENTION AND/OR TREATMENT OF METABOLIC SYNDROME AND RELATED DISORDERS

#975
US20240216447A1
Human necessities

Selection and Use of Melatonin Supporting Bacteria to Reduce Infantile Colic

#976
US20240216448A1
Human necessities

COMPOSITION FOR INHIBITING BIOFILM COMPRISING LACTOBACILLUS RHAMNOSUS AS ACTIVE INGREDIENT

#977
US20240216449A1
Human necessities

STRAINS OF PROBIOTIC BACTERIA FOR USE IN A PREVENTIVE METHOD OF TREATMENT OR IN AN ADJUVANT METHOD OF TREATMENT OF VIRAL RESPIRATORY INFECTIONS

#978
US20240216450A1
Human necessities

NOVEL BACTERIOPHAGE HAVING CLOSTRIDIUM PERFRINGENS-SPECIFIC BACTERICIDAL EFFECT AND ANTIBACTERIAL COMPOSITION COMPRISING SAME

#979
US20240216451A1
Human necessities

MANUFACTURING METHOD FOR COMPOSITION PROMOTING RECOVERY OF BONE FRACTURE

#980
US20240216452A1
Human necessities

MANUFACTURING METHOD FOR COMPOSITION PROMOTING BONE DENSITY ENHANCEMENT

#981
US20240216453A1
Human necessities

EXTRACTION OF COMPOUNDS WITH BETA-CARYOPHYLLENE, COMPOSITIONS AND USES THEREOF

#982
US20240216454A1
Human necessities

METHOD FOR TREATING DERMATITIS AND PHARMACEUTICAL COMPOSITION FOR TREATING DERMATITIS CONTAINING AN ADENOSTEMMA LAVENIA EXTRACT

#983
US20240216455A1
Human necessities

NON-STEROIDAL TOPICAL COMPOSITION AND METHOD THEREOF

#984
US20240216456A1
Human necessities

ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS

#985
US20240216457A1
Human necessities

ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS

#986
US20240216458A1
Human necessities

Composition for the prevention, improvement or treatment of allergic diseases comprising an extract of Cassia mimosoides L. as an active ingredient

#987
US20240216459A1
Human necessities

COMPOSITION FOR PREVENTING AND/OR AMELIORATING MENSTRUAL CYCLE SYMPTOMS AND/OR DISCOMFORTS, AND METHODS OF PRODUCING AND USING THE SAME

#988
US20240216460A1
Human necessities

SALVIA PLEBIA AND SCUTELLARIAE RADIX COMPOUND ACNE CREAM, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

#989 ✅ Patent 12,133,876 granted on 2024-11-05
US20240216461A1
Human necessities

TryNOVID boosts immune system against viruses and variants

#990
US20240216462A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR ENHANCING IMMUNITY OR ANTI-CANCER ACTIVITY INCLUDING EXTRACT OF PSEUDOLYSIMACHION NAKAIANUM (OHWI) T.YAMAZ AS ACTIVE INGREDIENT

#991
US20240216463A1
Human necessities

COMPOSITION COMPRISING COFFEE, COFFEE EXTRACT, AND BYPRODUCT AS ACTIVE INGREDIENT FOR PREVENTION OF CANCER METASTASIS OR FOR ALLEVIATION OR TREATMENT OF CANCER

#992
US20240216464A1
Human necessities

IL1RA DERIVED PEPTIDES FOR TREATMENT OF DIABETIC NEPHROPATHY

#993
US20240216465A1
Human necessities

METHOD FOR TREATING REFRACTORY BRAIN TUMOR

#994
US20240216466A1
Human necessities

COMPOSITIONS FOR TREATING HEART DISEASE BY INHIBITING THE ACTION OF mAKAP-beta

#995
US20240216467A1
Human necessities

DOSAGE REGIME FOR APOLIPOPROTEIN FORMULATIONS

#996
US20240216468A1
Human necessities

NOVEL ANTI-INFLAMMATORY THERAPEUTICS AND METHOD OF USE THEREOF

#997
US20240216469A1
Human necessities

SYNTHETIC TISSUE BARRIERS AND USES THEREOF

#998
US20240216470A1
Human necessities

INDUCIBLE IL-2 AND PD-1/PD-L1 COMBINATION THERAPY

#999
US20240216471A1
Human necessities

COMBINATION THERAPY OF PD-1-TARGETED IL-2 VARIANT IMMUNOCYTOKINES AND ANTIBODIES AGAINST HUMAN PD-L1

#1000
US20240216472A1
Human necessities

ENHANCED EFFICACY OF TOLEROGENIC VACCINATION

#1001
US20240216473A1
Human necessities

IL15/IL15R ALPHA HETERODIMERIC FC-FUSION PROTEINS FOR THE EXPANSION OF NK CELLS IN THE TREATMENT OF SOLID TUMOURS

#1002
US20240216474A1
Human necessities

ACTIVATABLE INTERFERON POLYPEPTIDES AND METHODS OF USE THEREOF

#1003 ✅ Patent 12,214,017 granted on 2025-02-04
US20240216475A1
Human necessities

GLP-1 compositions and uses thereof

#1004
US20240216476A1
Human necessities

COMBINATION OF BITTER RECEPTOR AGONIST AND GUT-SIGNALING COMPOUND

#1005
US20240216477A1
Human necessities

USE OF THERAPEUTIC PLASMA EXCHANGE AND LOW VOLUME PLASMA EXCHANGE FOR THE TREATMENT OF A COGNITIVE IMPAIRMENT

#1006 ✅ Patent 12,350,321 granted on 2025-07-08
US20240216478A1
Human necessities

FIBROIN-DERIVED PROTEIN COMPOSITION

#1007 ✅ Patent 12,215,360 granted on 2025-02-04
US20240216479A1
Human necessities

Encapsulation of dual-enzyme composition for preventing, treating and/or alleviating veisalgia and symptoms associated therewith

#1008
US20240216480A1
Human necessities

TREATMENT OF EYE DISEASES WITH FRUCTOSYL-AMINO ACID OXIDASE

#1009
US20240216481A1
Human necessities

COMPOSITION FOR TREATING OF FACIAL DYSMORPHISM IN MUCOPOLYSACCHARIDOSIS

#1010
US20240216482A1
Human necessities

SYSTEMS AND METHODS FOR REGULATING ABERRANT GENE EXPRESSIONS

#1011
US20240216483A1
Human necessities

THERAPEUTIC REGIMEN WITH DNASE

#1012
US20240216484A1
Human necessities

BROMELAIN PROTEASE, BROMELAIN, JACALIN-LIKE LECTIN, EXTRACT FROM THE STEM AND/OR THE FRUIT OF A PINEAPPLE PLANT, COMBINATION PREPARATION, BROMELAIN PROTEASE INHIBITOR, PROTEIN/PROTEASE MIX, AND GLYCATED BROMELAIN PROTEIN FORMED BY EXOGENOUS NON-ENZYMATIC GLYCATION, FOR USE IN THE TREATMENT OR PROPHYLAXIS OF VIRUS INFECTIONS CAUSED BY CORONAVIRUSES IN A HUMAN OR ANIMAL

#1013
US20240216485A1
Human necessities

METHOD OF TREATING OR REDUCING EFP

#1014
US20240216486A1
Human necessities

INJECTABLE BOTULINUM TOXIN METHODS FOR TREATING HEADACHES

#1015
US20240216487A1
Human necessities

INTRAMUSCULAR COMPOSITIONS OF BOTULINUM NEUROTOXINS

#1016 ✅ Patent 12,285,469 granted on 2025-04-29
US20240216488A1
Human necessities

Complex of botulinum neurotoxin E and its binding protein as a formulation with enhanced potency

#1017
US20240216489A1
Human necessities

IMMUNE TOLERANCE INDUCTION AND ERADICATION OF ANTI-DRUG ANTIBODIES (ADA) TO THERAPEUTIC FACTOR VIII

#1018
US20240216490A1
Human necessities

Autoantigens Engineered to Suppress Autoimmune Response

#1019
US20240216491A1
Human necessities

NEOGLYCOCONJUGATES AS VACCINES AND THERAPEUTIC TOOLS

#1020
US20240216492A1
Human necessities

USE OF ONCOLYTIC ADENOVIRUS FOR THE TREATMENT OF PEDIATRIC BRAIN CANCER

#1021
US20240216493A1
Human necessities

CANCER THERAPY COMPOSITIONS AND USES THEREOF

#1022
US20240216494A1
Human necessities

PROTEINS AND IMMUNIZING COMPOSITIONS CONTAINING KLEBSIELLA PROTEINS AND METHODS OF USE

#1023
US20240216495A1
Human necessities

COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIUM DIFFICILE

#1024
US20240216496A1
Human necessities

RECOMBINANT LACTIC ACID BACTERIUM AND METHOD THEREOF FOR SIMULTANEOUS TREATMENT AND/OR PREVENTION OF DUST MITE AND COCKROACH ALLERGIES

#1025
US20240216497A1
Human necessities

Ferritin Proteins

#1026
US20240216498A1
Human necessities

LARGE-SCALE FLAVIVIRAL VACCINE PRODUCTION AND MANUFACTURE

#1027 ✅ Patent 12,343,391 granted on 2025-07-01
US20240216499A1
Human necessities

PROTEIN-BASED NANOPARTICLE VACCINE FOR METAPNEUMOVIRUS

#1028
US20240216500A1
Human necessities

RESPIRATORY VIRUS COMBINATION VACCINES

#1029
US20240216501A1
Human necessities

NEOANTIGEN ADJUVANT AND MAINTENANCE THERAPY

#1030 ✅ Patent 12,257,302 granted on 2025-03-25
US20240216502A1
Human necessities

Universal vaccine platform

#1031
US20240216503A1
Human necessities

METHODS OF TREATING ALLERGIES

#1032
US20240216504A1
Human necessities

METHOD FOR PREVENTING OR TREATING OF HEMATHROSIS

#1033
US20240216505A1
Human necessities

INDUCIBLE CYTOKINE PRODRUG AND PD-1/PD-L1 COMBINATION THERAPY

#1034
US20240216506A1
Human necessities

ANTIBODY COMPOSITION

#1035
US20240216507A1
Human necessities

SARS-COV-2-SPECIFIC T CELLS AND METHODS OF TREATMENT USING THEM

#1036
US20240216508A1
Human necessities

ENGINEERED T CELLS CONDITIONALLY EXPRESSING A RECOMBINANT RECEPTOR, RELATED POLYNUCLEOTIDES AND METHODS

#1037
US20240216509A1
Human necessities

CHIMERIC POLYPEPTIDES, NUCLEIC ACID MOLECULES, CELLS, AND RELATED METHODS

#1038
US20240216510A1
Human necessities

CHIMERIC ANTIGEN RECEPTORS TO SIALYL-TN GLYCAN ANTIGEN

#1039 ✅ Patent 12,311,026 granted on 2025-05-27
US20240216511A1
Human necessities

Therapeutic uses for sodium thiosulfate formulations

#1040
US20240216512A1
Human necessities

INTRACAMERAL IMPLANT FOR TREATMENT OF AN OCULAR CONDITION

#1041
US20240216513A1
Human necessities

FATTY ACID-BIFUNCTIONAL DEGRADER CONJUGATES AND THEIR METHODS OF USE

#1042
US20240216514A1
Human necessities

NOVEL ANTITUMOR COMPOUNDS AND RELATED METHODS OF MANUFACTURE AND USE

#1043
US20240216515A1
Human necessities

COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS

#1044 ✅ Patent 12,168,058 granted on 2024-12-17
US20240216516A1
Human necessities

Glutarimide-containing KRAS-mutant degrader compounds and uses thereof

#1045
US20240216517A1
Human necessities

PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF LUNG CANCER

#1046
US20240216518A1
Human necessities

EXTENDED-RELEASE IMMUNE CELL ENGAGING PROTEINS AND METHODS OF TREATMENT

#1047
US20240216519A1
Human necessities

SMALL HYDROPHOBIC PROTEIN DRUG CONJUGATES AND USES THEREOF

#1048
US20240216520A1
Human necessities

PEPTIDE-SMALL INTERFERING RNA-HYALURONIC ACID NANOPARTICLES AND METHODS OF USE THEREOF

#1049
US20240216521A1
Human necessities

METHODS OF PREPARING CELL-BINDING AGENT-DRUG CONJUGATES

#1050
US20240216522A1
Human necessities

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FRIEDREICH'S ATAXIA

#1051
US20240216523A1
Human necessities

Compositions and Methods for Targeting Lipid Nanoparticle Therapeutics to Stem Cells

#1052
US20240216524A1
Human necessities

Chemoselective Rapid Azo-Coupling Reaction for Bioconjugation

#1053
US20240216525A1
Human necessities

ENZYME-TRIGGERED SELF-REACTING LINKER HAVING IMPROVED PHYSICOCHEMICAL AND PHARMACOLOGICAL PROPERTIES

#1054
US20240216526A1
Human necessities

PREPARATION METHOD FOR DUAL-DRUG-LINKER OF ADC AND USE THEREOF

#1055
US20240216527A1
Human necessities

VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF TUMORS

#1056
US20240216528A1
Human necessities

APPLICATION OF PHARMACEUTICAL COMPOSITION HAVING SPECIFIC DRUG-TO-LIPID RATIO IN ANTITUMOR

#1057
US20240216529A1
Human necessities

EXTRACELLULAR VESICLES WITH TARGETING MOIETY

#1058
US20240216530A1
Human necessities

Compositions and Methods for Treating Skeletal Muscle Disease

#1059
US20240216531A1
Human necessities

CHITOSAN-CONTAINING NANOPARTICLES FOR DELIVERY OF POLYNUCLEOTIDES

#1060
US20240216532A1
Human necessities

COMPOSITIONS AND METHODS RELATED TO MEGAKARYOCYTE-DERIVED EXTRACELLULAR VESICLES FOR FANCONI ANEMIA

#1061
US20240216533A1
Human necessities

HERPES SIMPLEX VIRUS AND USE THEREOF

#1062
US20240216534A1
Human necessities

DIRECT RAAV-MEDIATED IN VIVO GENE EDITING OF HEMATOPOIETIC STEM CELLS

#1063
US20240216535A1
Human necessities

NON-VIRAL DNA VECTORS EXPRESSING ANTI-CORONAVIRUS ANTIBODIES AND USES THEREOF

#1064
US20240216536A1
Human necessities

SECRETED UBE3A FOR TREATMENT OF NEUROLOGICAL DISORDERS

#1065
US20240216537A1
Human necessities

GENE THERAPY FOR NEUROPROTECTION

#1066
US20240216538A1
Human necessities

GENOMIC EDITING OF COMPLEMENT

#1067
US20240216539A1
Human necessities

VECTOR FOR DELIVERING ACTIVE AGENT TO NERVOUS SYSTEM, AND USE THEREOF

#1068
US20240216540A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING STEREOCILIN DUAL VECTOR SYSTEMS

#1069
US20240216541A1
Human necessities

GENE THERAPY FOR ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY

#1070
US20240216542A1
Human necessities

GM3 SYNTHASE VECTORS AND USES THEREOF

#1071
US20240216543A1
Human necessities

MICRODYSTROPHIN GENE THERAPY ADMINISTRATION FOR TREATMENT OF DYSTROPHINOPATHIES

#1072
US20240216544A1
Human necessities

METHODS AND COMPOSITIONS FOR EXPRESSION OF EDITING PROTEINS

#1073
US20240216545A1
Human necessities

MRNA DELIVERY CONSTRUCTS AND METHODS OF USING THE SAME

#1074
US20240216546A1
Human necessities

MODEL OPTIMIZED DRUG AND DRUG COMBINATIONS FOR TREATING CANCERS

#1075
US20240216547A1
Human necessities

USE OF FLUORESCEIN DICARBONATE DERIVATIVES AS A CELL MARKER

#1076
US20240216548A1
Human necessities

METHOD FOR PREPARING THERAGNOSTIC CARBON QUANTUM-DOT NANOMEDICINES FOR TARGETED DRUG DELIVERY TO ACUTE-MYELOID LEUKEMIA

#1077
US20240216549A1
Human necessities

ENHANCEMENT OF TREATMENT WITH IMMUNOTHERAPEUTIC AGENTS

#1078
US20240216550A1
Human necessities

COMBINATION COMPRISING A NEUROTENSIN RECEPTOR BINDING COMPOUND AND NAPOLI

#1079
US20240216551A1
Human necessities

RADIOPHARMACEUTICALS BASED ON ((R)-1-((6-HYDRAZINYLNICOTINOYL)-D-ALANYL)PYRROLIDIN-2-YL)BORONIC ACID (HYNIC-IFAP) FOR DETECTING THE OVEREXPRESSION OF FIBROBLAST ACTIVATION PROTEIN

#1080 ✅ Patent 12,138,322 granted on 2024-11-12
US20240216552A1
Human necessities

Method of preventing the development of melanoma

#1081
US20240216553A1
Human necessities

DEVELOPMENT OF CD163 TARGETING AGENT FOR IMAGING AND THERAPY

#1082
US20240216554A1
Human necessities

RADIOIMMUNOCONJUGATES DIRECTED TO NKG2D LIGANDS FOR THE TREATMENT OF CANCER

#1083
US20240216555A1
Human necessities

TARGETING AND TREATMENT OF CANCEROUS CELLS USING RADIOLABELED GRP78-BINDING AGENTS

#1084
US20240216556A1
Human necessities

PEPTIDE-FC FUSIONS FOR TREATING AMYLOID DISORDERS

#1085
US20240216557A1
Human necessities

RADIOLIGAND BINDING TO ANTI-DLL3 ANTIBODIES FOR PRETARGETED PET IMAGING AND THERAPEUTIC USES THEREOF

#1086
US20240216558A1
Human necessities

BACTERIAL LIGHT SOURCE WITH HIGH QUALITY OF LIGHT

#1087
US20240216559A1
Human necessities

ULTRAVIOLET LIGHT IRRADIATION SYSTEM AND ULTRAVIOLET LIGHT IRRADIATION METHOD

#1088
US20240216560A1
Human necessities

DECONTAMINATION SYSTEM HAVING A MODULAR DECONTAMINATION UNIT

#1089
US20240216561A1
Human necessities

A CONTROL DEVICE FOR CONTROLLING AN ULTRAVIOLET LIGHT-BASED DISINFECTION DEVICE

#1090
US20240216562A1
Human necessities

NASAL SWAB APPARATUS AND METHOD FOR APPLYING A CLEANING SOLUTION

#1091
US20240216563A1
Human necessities

DEVICES AND METHODS FOR MEASURING EFFICACY OF ULTRAVIOLET LIGHT DISINFECTION

#1092 ✅ Patent 12,109,338 granted on 2024-10-08
US20240216564A1
Human necessities

Germicidal lighting

#1093
US20240216565A1
Human necessities

DECONTAMINATION UNIT AND METHOD FOR DECONTAMINATING A SPACE

#1094
US20240216566A1
Human necessities

DIFFUSER SYSTEM CONTROLLABLE BY A MOBILE APPLICATION

#1095
US20240216567A1
Human necessities

PHOTOCATALYST DEVICE

#1096 ✅ Patent 12,280,183 granted on 2025-04-22
US20240216568A1
Human necessities

Bulb lamp

#1097
US20240216569A1
Human necessities

STERILIZATION APPARATUS

#1098
US20240216570A1
Human necessities

AIR PURIFICATION MODULE AND REFRIGERATOR COMPRISING THE SAME

#1099
US20240216571A1
Human necessities

CHITOSAN SUPERFINE FIBER SYSTEMS

#1100
US20240216572A1
Human necessities

Biomaterials for the prevention and the treatment of tissue disorders

#1101
US20240216573A1
Human necessities

COMPOSITIONS COMPRISING CROSS-LINKED HYALURONIC ACID AND METHODS OF USE THEREOF

#1102
US20240216574A1
Human necessities

Citrate-Based Bone Grafting Materials

#1103
US20240216575A1
Human necessities

BIOPOLYMER SCAFFOLDS AND METHODS FOR PRODUCTION OR USE THEREOF

#1104
US20240216576A1
Human necessities

HYALURONIC ACID CROSS-LINKED PRODUCT, AND FILLER COMPOSITION COMPRISING SAME

#1105
US20240216577A1
Human necessities

TISSUE FIBROSIS INHIBITOR IN WHICH BIOCOMPATIBLE POLYMER IS USED

#1106
US20240216578A1
Human necessities

COMPOSITE ULTRATHIN COATING FILM WITH INHIBITORY ACTIVITY AGAINST HYPERINFLAMMATORY RESPONSE AND BACTERIA, IMPLANT INCLUDING SAME, AND PREPARATION METHOD THEREFOR

#1107
US20240216579A1
Human necessities

DESCEMET MEMBRANE ENDOTHELIAL KERATOPLASTY (DMEK) ASSEMBLIES AND INJECTORS WITH FRICTION-REDUCING COATINGS

#1108
US20240216580A1
Human necessities

METHOD FOR PRODUCING DECELLULARIZED BIOMATERIAL, DECELLULARIZED BIOMATERIAL AND USE THEREOF

#1109
US20240216581A1
Human necessities

PHOTOCURABLE COMPOSITE HYDROGEL MATRIX PRECURSOR, PREPARATION METHOD THEREOF AND SCAFFOLD WITH SAME

#1110
US20240216582A1
Human necessities

ENGINEERED NERVE GRAFTS, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT USING THE SAME

#1111 ✅ Patent 12,370,289 granted on 2025-07-29
US20240216583A1
Human necessities

DOUBLE NETWORK HYDROGEL WITH ANIONIC POLYMER AND USES THEREOF

#1112
US20240216584A1
Human necessities

METHODS, SYSTEMS, AND DEVICES FOR GENERATING DEFINED FIBER CONSTRUCTS

#1113
US20240216585A1
Human necessities

PEG BICOMPONENT SELF-ADHESIVE ABSORBABLE BIOLOGICAL PATCH AND PREPARATION METHOD AND USE THEREOF

#1114
US20240216586A1
Human necessities

SILICONE PATCH COMPRISING METAL-ORGANIC FRAMEWORK AND SILICONE COMPOSITION

#1115
US20240216587A1
Human necessities

Multi-Layered Graft for Tissue Engineering Applications

#1116
US20240216588A1
Human necessities

HEART VALVE THAT INCLUDES COATING MATERIAL

#1117
US20240216589A1
Human necessities

DRUG DELIVERY COMPOSITIONS AND METHODS OF CONTROLLING DRUG DELIVERY RATES OF SUBCUTANEOUS SENSORS

#1118
US20240216590A1
Human necessities

Direct Drive Centrifuge

#1119
US20240216591A1
Human necessities

BREAST PUMP

#1120
US20240216592A1
Human necessities

PREPARING AN EXTRACORPOREAL BLOOD TREATMENT APPARATUS

#1121
US20240216593A1
Human necessities

WATER PRE-TREATMENT SYSTEM FOR MEDICAL DEVICE

#1122
US20240216594A1
Human necessities

DIALYSIS SOLUTION BAG ADAPTOR SYSTEM

#1123
US20240216595A1
Human necessities

PORTABLE HEMOFILTRATION COMPONENTS, SYSTEMS, AND METHODS

#1124
US20240216596A1
Human necessities

Medical Functional Device for Hemodialysis, Balancing Device and Method

#1125
US20240216597A1
Human necessities

SYSTEM AND METHOD FOR REMOVAL OF FLUID FROM A BIOLOGICAL FLUID FILTER

#1126
US20240216598A1
Human necessities

Systems and Methods of Gas Removal from a Wearable Device

#1127
US20240216599A1
Human necessities

EXTRACORPOREAL CIRCUIT SUPPORT

#1128
US20240216600A1
Human necessities

METHODS FOR ROUTING A GUIDEWIRE FROM A FIRST VESSEL AND THROUGH A SECOND VESSEL IN LOWER EXTREMITY VASCULATURE

#1129
US20240216601A1
Human necessities

MEDICAL WASTE FLUID COLLECTION AND DISPOSAL SYSTEM

#1130 ✅ Patent 12,121,694 granted on 2024-10-22
US20240216602A1
Human necessities

Tamper evident closure container

#1131
US20240216603A1
Human necessities

SYRINGE STABILIZER

#1132
US20240216604A1
Human necessities

PCA PUMP PROGRAMMING AND PATIENT HISTORY USER INTERFACE

#1133
US20240216605A1
Human necessities

Infusion Set and Inserter Assembly Apparatuses, Systems, and Methods

#1134
US20240216606A1
Human necessities

Infusion Set and Inserter Assembly Apparatuses, Systems, and Methods

#1135
US20240216607A1
Human necessities

SYSTEM AND METHOD FOR DRAWING A SOLUTION

#1136
US20240216608A1
Human necessities

Smart Monitoring of an Intravenous Access Site Using Sensors for Continuous Monitoring

#1137
US20240216609A1
Human necessities

Infusion Pump and Control Method Thereof

#1138
US20240216610A1
Human necessities

Methods and systems for closed-loop control of drug administration

#1139
US20240216611A1
Human necessities

ON-BODY MEDICAMENT DELIVERY DEVICES FOR ADMINISTRATION OF MEDICAMENT

#1140
US20240216612A1
Human necessities

DUAL CHAMBER INJECTION SYSTEM AND METHODS OF USE THEREOF

#1141
US20240216613A1
Human necessities

SYRINGE BARREL WITH VARYING SILICONE LAYER THICKNESSES, SYRINGE COMPRISING SAME AND USES THEREOF

#1142
US20240216614A1
Human necessities

SYRINGE WITH LUER-LOCK CONNECTOR PROVIDED WITH A TAMPER-PROOF CAP

#1143
US20240216615A1
Human necessities

Coded Housing Components for an Injection Device

#1144 ✅ Patent 12,156,996 granted on 2024-12-03
US20240216616A1
Human necessities

Autoinjector

#1145
US20240216617A1
Human necessities

Mixing Syringe

#1146
US20240216618A1
Human necessities

Autoinjector

#1147
US20240216619A1
Human necessities

IMPROVED PORTABLE SUBSTANCE-INJECTION DEVICE

#1148
US20240216620A1
Human necessities

EVAPORATION CHAMBER AND CHANNEL MODULE FOR ACTIVE AEROSOL SUCTION DEVICE

#1149
US20240216621A1
Human necessities

SYSTEMS AND METHODS FOR INTELLIGENT VAPORIZERS

#1150
US20240216622A1
Human necessities

ACTIVE SMOKE FILTRATION FOR INSUFFLATION

#1151
US20240216623A1
Human necessities

VALVED HOLDING CHAMBER WITH EXHALATION FILTER

#1152
US20240216624A1
Human necessities

LIQUID FEED SYSTEMS FOR AN AEROSOL DELIVERY DEVICE

#1153
US20240216625A1
Human necessities

AEROSOL PRODUCTION ASSEMBLY INCLUDING SURFACE WITH MICRO-PATTERN

#1154
US20240216626A1
Human necessities

CONTROL OF PRESSURE FOR BREATHING COMFORT

#1155
US20240216627A1
Human necessities

RESPIRATORY PRESSURE THERAPY SYSTEM

#1156
US20240216628A1
Human necessities

GAS INHALATION DELIVERY DEVICES AND RELATED METHODS

#1157
US20240216629A1
Human necessities

METHODS AND SYSTEMS FOR MANUAL VENTILATION

#1158
US20240216630A1
Human necessities

DEVICE AND METHOD FOR SELECTING RESPIRATORY THERAPY

#1159
US20240216631A1
Human necessities

CUFF PRESSURE CONTROL SYSTEM AND METHOD

#1160
US20240216632A1
Human necessities

APPARATUS AND METHOD FOR SELECTING POSITIVE AIRWAY PRESSURE MASK INTERFACE

#1161
US20240216633A1
Human necessities

SEAL-FORMING STRUCTURE OF PATIENT INTERFACE WITH MULTIPLE SEALING MATERIALS

#1162
US20240216634A1
Human necessities

RESPIRATORY MASK HAVING A MAGNETICALLY SUPPORTED CUSHION

#1163
US20240216635A1
Human necessities

UNOBTRUSIVE NASAL MASK

#1164
US20240216636A1
Human necessities

OXYGEN GAS CONCENTRATOR WITH OUTLET ACCUMULATOR

#1165
US20240216637A1
Human necessities

HEAT AND MOISTURE EXCHANGE DEVICES, ELEMENTS AND ASSEMBLIES

#1166
US20240216638A1
Human necessities

TEMPERATURE CONTROL METHOD AND SYSTEM FOR HEATED BREATHING-CIRCUIT, AND BREATHING ASSISTANCE APPARATUS THEREOF

#1167
US20240216639A1
Human necessities

CONSTANT POWER CONTROL DEVICE OF ACTIVE VAPORIZATION SUCTION APPARATUS

#1168
US20240216640A1
Human necessities

RESPIRAORY THERAPY KITS

#1169
US20240216641A1
Human necessities

LIGHT THERAPY SYSTEM AND METHOD

#1170
US20240216642A1
Human necessities

SYSTEM AND METHOD FOR BIOFEEDBACK

#1171
US20240216643A1
Human necessities

SENSORY TRANSMISSION SYSTEM, SENSORY TRANSMISSION METHOD, AND COMPUTER-READABLE STORAGE MEDIUM

#1172
US20240216644A1
Human necessities

CATHETER INCLUDING MULTI-LAYER OUTER JACKET

#1173
US20240216645A1
Human necessities

DUAL LUMEN HEMOSTATIC VALVE FOR GUIDING CATHETER

#1174
US20240216646A1
Human necessities

SHAFT DEFLECTION CONTROL ASSEMBLY FOR ENT GUIDE INSTRUMENT

#1175
US20240216647A1
Human necessities

CATHETER HANDLE AND CATHETER WITH THE SAME

#1176
US20240216648A1
Human necessities

STEERABLE GUIDE CATHETER

#1177
US20240216649A1
Human necessities

Management of Catheters and Accessories During Intravascular Catheter Maintenance

#1178
US20240216650A1
Human necessities

Catheter Adapter with Integrated Adhesive Dispenser

#1179
US20240216651A1
Human necessities

GUIDE CATHETER CONTROL FLEXIBLE TRACK

#1180
US20240216652A1
Human necessities

SHEATH ASSEMBLY FOR CATHETER PUMP

#1181
US20240216653A1
Human necessities

INTRAVASCULAR DEVICE WITH A MATCHED DIAMETER CORE WIRE JOINT

#1182
US20240216654A1
Human necessities

VASCULAR INTERVENTION PROCEDURE DEVICE

#1183
US20240216655A1
Human necessities

DOUBLE-BALLOON THROMBOLYSIS AND THROMBECTOMY DEVICE

#1184
US20240216656A1
Human necessities

MEDICAL DEVICE HAVING STEPPED LEAD WIRE

#1185
US20240216657A1
Human necessities

SHUNT SYSTEMS AND METHODS WITH TISSUE GROWTH PREVENTION

#1186
US20240216658A1
Human necessities

BIODEGRADABLE SPINY MILLI-BALL ROBOT

#1187
US20240216659A1
Human necessities

MICROSTRUCTURE CARTRIDGE AND MICROSTRUCTURE APPLICATOR

#1188
US20240216660A1
Human necessities

TATTOO PRACTICE DEVICE AND OPERATION PEN USING THE SAME

#1189
US20240216661A1
Human necessities

NON-INVASIVE AGENT APPLICATOR

#1190
US20240216662A1
Human necessities

APPARATUS AND METHOD FOR CANNULATION OF VASCULAR ACCESS VESSEL

#1191
US20240216663A1
Human necessities

VASCULAR ACCESS CHANNEL AND METHODS

#1192
US20240216664A1
Human necessities

NEUROSURGICAL DEVICE

#1193
US20240216665A1
Human necessities

Barrier Band

#1194
US20240216666A1
Human necessities

INFUSION SITE OF A BLOOD TUBING SYSTEM

#1195
US20240216667A1
Human necessities

PERITONEAL DIALYSIS CAPS, SYSTEMS & METHODS

#1196 ✅ Patent 12,268,837 granted on 2025-04-08
US20240216668A1
Human necessities

Neutral displacement connector

#1197
US20240216669A1
Human necessities

BLOOD CIRCULATION SYSTEM

#1198
US20240216670A1
Human necessities

PORTABLE VENTRICULAR ASSIST SYSTEM WITH A MULTI-CHANNEL OPTICAL PRESSURE SENSOR

#1199
US20240216671A1
Human necessities

CATHETER BLOOD PUMP SHROUDS AND ASSEMBLY THEREOF

#1200
US20240216672A1
Human necessities

Method and Apparatus for Assisting a Heart